Salugan, Nina H.

HRN: 26-48-68  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/20/2026
06/26/2026
IV
2.25
8q
Sacral Ulcer
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: